Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of adjuvanted recombinant zoster vaccine in adult autologous hematopoietic stem cell transplant recipients
2012-000138-20Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in herpes zoster (HZ) comparing Herpes Zoster vaccine GSK 1437173A with Placebo (2 arms). Primary endpoint: Occurrence of confirmed herpes zoster cases. Started Apr 2012; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2012-000138-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000138-20.